Background: Postprandial lipemia is associated with endothelial dysfunction. Remnant-like particles (RLP) have been suggested to contribute to these adverse vascular effects. We investigated the effect of cerivastatin and gemfibrozil upon oral fat load induced changes in endothelial function and postprandial lipid profile in vivo. Methods: In a randomized cross-over trial, 15 healthy volunteers received cerivastatin (0.4 mg once daily), gemfibrozil (900 mg once daily) or placebo for 3 weeks. Lipid profiles and flow mediated dilation (FMD) were assessed before and 4 h after an oral fat load. Endothelium-independent dilation was tested after nitroglycerine 0.4 mg sublingual spray. Results: After the placebo period, the oral fat load induced an increase in triglycerides (TG) and RLP-cholesterol (RLP-C) (0.960.7 and 0.0860.04 mmol / l, respectively) and a significant decrease in FMD (9.163.4 to 4.363.3%, P,0.05). After gemfibrozil, TG increase was attenuated (0.560.5 mmol / l), whereas RLP-C increase (0.0560.09 mmol / l) and FMD decrease (9.063.8 to 5.262.6%, P,0.05) were not different from placebo therapy. Cerivastatin did not affect TG increase (0.760.8 mmol / l). RLP-C increase (0.0260.07 mmol / l) and FMD (7.962.6 to 8.462.8%) change were attenuated significantly compared to placebo. Endotheliumindependent vasodilatation remained unaltered throughout the protocol. Conclusion: Cerivastatin, but not gemfibrozil significantly reduces RLP-C increase after an oral fat load in combination with a reversal of fat-load induced endothelial dysfunction. The present data imply that lowering of RLP-C, rather than lowering of total TG levels, may contributes to the prevention of endothelial dysfunction after an oral fat load during statin use.
Introduction
dysfunction [8] [9] [10] , reaching a maximal impairment 4 h after a standard fat load [10] . The latter time point Increasing experimental and clinical evidence suggests coincides with the triglyceride (TG) and RLP-C peak upon that triglyceride-rich lipoproteins (TRL) and in particular fat loading [11, 12] . In the present study we hypothesized remnant-like particles (RLP), that circulate postprandially, that in particular RLP particles are responsible for the may contribute to the atherosclerotic process, and subadverse vascular effects in the postprandial phase. sequently to cardiovascular disease progression [1] [2] [3] [4] . In
The currently accepted lipid-lowering strategies clearly line, coronary endothelial dysfunction, an emerging surrodiffer in their effect on postprandial lipid metabolism. We gate endpoint for cardiovascular morbidity [5] , is negapreviously demonstrated a significant decrease in RLP-C tively correlated to RLP-cholesterol (RLP-C) levels [6, 7] . levels with only minor effects on TG levels during statin Recently, we and others have shown that an acute lipid therapy in patients with heterozygous familial hypercholesload is associated with a consistent onset of endothelial terolemia [11] . In contrast, fibrates have been reported to significantly reduce TG levels, whereas their effect on RLP-C levels is unknown. In view of these divergent effects on postprandial lipid profile, we assessed the effects 2.3. FMD assessment of these lipid lowering drugs on both endothelial function and postprandial lipid metabolism. Using a double-blind,
The ultrasound measurements were performed in supine placebo-controlled cross-over design, flow-mediated dilataposition at the elbow of the right arm using a vessel tion before and after an oral fat load was evaluated in 15 wall-movement system (Wall Track System, Pie Medical, healthy volunteers using either cerivastatin 0.4 mg once Maastricht, The Netherlands), as described previously daily (o.d.), gemfibrozil 900 mg once daily (o.d.) or [8, 9] . In short, an optimal two-dimensional B-mode image placebo.
of the brachial artery was obtained. An M-line perpendicular to the vessel was selected. Next, the ultrasound system was switched to M-mode. The vessel-movement detector system repeatedly registered end-diastolic vessel 2. Methods diameter during a period of five to six cardiac cycles. This procedure was performed three times. The measurements 2.1. Subjects were averaged to provide for a mean baseline diameter measurement. Fifteen healthy male volunteers, aged 18-36, particiBy inflation of a blood pressure cuff for 4 min at a pated in this study. All individuals, except one, who had an pressure of 100 mmHg above the systolic blood pressure, occasional borderline blood pressure elevation, were norischemia was applied to the forearm distal to the location motensive (systolic blood pressure ,140 mmHg and of the transducer. Ultrasonography continued for 3 min diastolic blood pressure ,90 mmHg), non-smoking and after cuff release with measurements at 30-s intervals. The had no history of cardiovascular disease, or family history widest lumen diameter was taken as a measure for of premature vascular disease. All subjects had fasting TG maximal diameter. Next, 0.4 mg sublingual nitroglycerine and cholesterol concentrations below 2.0 and 6.0, mmol / l, spray was administered as an endothelium-independent respectively. The subjects refrained from using medication.
vasodilator. Nitroglycerine measurements were obtained at The study was approved by the Medical Ethics Committee 2.5 and 5 min. Post fat-load FMD studies were performed of the University Medical Center Utrecht and written 4 h after the oral fat load. The latter time point has been informed consent was obtained from all participants. The shown to correspond to the largest postprandial decrease in investigation conforms with the principles outlined in the FMD response [10] . FMD and NTG were expressed as a Declaration of Helsinki (Cardiovascular Research percentage change relative to baseline diameter. Intra-and 1997;35:2-3).
interobserver variability of this method at our institution is 3.6 and 4.1%, respectively.
Study design
A randomized, cross-over trial was performed compar-2.4. Laboratory determinations ing cerivastatin (0.4 mg o.d.), gemfibrozil (900 mg o.d.) and placebo. All subjects were assigned randomly to Plasma was obtained by centrifugation at 3000 rpm for receive cerivastatin, gemfibrozil or placebo. After 3 weeks 15 min at 48C. TG and cholesterol were measured with a of treatment, each subject returned for evaluation of colorimetric assay (Monotest cholesterol kit no. 237574 vascular function, followed by 4 weeks of washout. Three and GPO-PAP no. 701912, Boehringer Mannheim, Gerweeks after cross-over, the subjects were restudied, and the many). Coefficient of variance for TG and cholesterol was same measurements were performed. ,5%. Cholesterol was determined in the HDL fraction The vasomotion study consisted of assessment of flow isolated by the heparin-MnCl dextran-sulphate precipi-2 mediated dilation (FMD) and nitroglycerin-induced vasotation. Low-density lipoprotein-cholesterol (LDL-C) was dilation (NTG; see below) before and after a standard oral calculated with the Friedewald formula. 2 fat load. The fat load consisted of 50 g fat / m body surface in the form of whipped cream (40% fat) [13] . All subjects refrained from drinking caffeine-containing bever-2.4.1. Postprandial lipoprotein remnants as RLP-C ages and eating 12 h before the vasomotion studies. At
The RLP-C fraction was prepared using an immunoeach visit, blood samples were drawn for laboratory separation technique described by Nakajima and co-workdeterminations of TG, total cholesterol (TC), HDL-cholesers [14, 15] . Briefly, 5 ml of serum was added to 300 ml of terol (HDL-C) and RLP-C concentrations before an oral mixed immunoaffinity gel suspension containing monofat load. Postprandial blood sampling was performed 4 h clonal anti-human apo-A-I (H-12) and anti-human Apo-Bafter the oral fat load, since previous studies in both 100 (JI-H) antibodies (Japan Immunoresearch Laboratorhealthy volunteers [12] as well as in patients with familial ies, Takasaki, Japan). The reaction mixture was gently hypercholesterolaemia [11] have shown peak levels of both shaken for 120 min at room temperature followed by RLP-C and TG at this time point. standing for 15 min. Next, 200 ml of the supernatant was withdrawn for the assay of RLP-C. Cholesterol (coefficient 3. Results of variance ,3%) in the RLP fraction was measured by an enzymatic assay using a Cobas Mira S auto-analyzer (ABX The general characteristics of the study group at baseline Diagnostis, Montpellier, France).
during placebo, cerivastatin and gemfibrozil treatment are shown in Table 1 . There were no statistically significant differences between baseline parameters, basal arterial 2.5. Statistical analysis diameter and basal FMD and NTG values.
The results of the lipid parameters, TG, TC, LDL-C and Group values are expressed as mean6standard devia-HDL-C, before as well as after the oral fat load and tion. Differences in FMD between the three treatment between the three treatment sessions are shown in Table 2 . periods and between baseline and post-fat loading were Upon fat loading, a significant increase in both TG and TC tested with a repeated measures ANOVA. Changes in lipid was observed in all treatment groups. Gemfibrozil treatprofile between treatment groups and before vs. after fat ment significantly lowered baseline TG concentration as loading were also tested with repeated measures ANOVA.
well as baseline TC and LDL-C concentrations (Table 2) . If variance ratios reached statistical significance, differIn contrast, cerivastatin treatment had no effect on the ences were analyzed with the Student-Newman-Keuls test baseline TG concentration, whereas TC and LDL-C levels for P,0.05.
were lowered significantly ( Table 2 ). Pearson's correlation or Spearman's rank correlations During placebo, fat loading induced an increase in TG, were applied to evaluate relationships between parameters.
TC and RLP-C (Tables 2 and 3 ). During gemfibrozil, TG A two-sided P-value of 0.05 was considered to be signifiincrease was significantly less compared to placebo cant. therapy (P50.02; Table 2 ), whereas TC and RLP-C Table 2 a Lipid profile before and 4 h after an oral fat load a fat load. Concomitantly, cerivastatin abolishes the postprandial increase in RLP-C, where the TG increase after a fat load is not significantly altered. In contrast, gemfibrozil clearly reduces the TG increase without significantly affecting the RLP-C increase after a fat load compared to placebo therapy. This combination of changes in 'postprandial' lipid profile and FMD during these drugs lend further support to the concept that lowering of RLP-C, rather than lowering of total TG levels, may be responsible for the abolition of 'postprandial' endothelial dysfunction during statin use.
Fat loading and FMD
The anti-atherosclerotic actions of endothelium-derived nitric oxide (NO) are thought to be of major importance in preventing the development and progression of atherosclerosis [16] . Indeed, evidence has accumulated to show that peripheral endothelial dysfunction predicts the presence of coronary cardiovascular disease [17, 18] , whereas incidents [5] . As a consequence, endothelial (dys)function is currently being evaluated as potential surrogate endincreases were comparable to the placebo period (Tables 2 point in cardiovascular prevention trials. In previous and 3). During cerivastatin, TG and TC increases upon fat studies, we and others have repeatedly shown a significant loading were comparable to the increase during placebo and reproducible impairment in FMD upon ingestion of an therapy (Table 2) . However, RLP-C levels did no longer oral fat load [8] [9] [10] . These observations may provide a show a significant increase upon fat loading (Table 3) .
rationale for the growing body of evidence from in vitro During placebo therapy an oral fat load induced an and in vivo studies showing that TRL, circulating preimpairment in FMD, i.e. 9.163.4 to 4.363.3% (Fig. 1) , dominantly in the postprandial period, are involved in the whereas NTG remained unaltered, i.e. 16.665.9 to course of atherogenesis. 14.164.1%. During gemfibrozil, the adverse effects of fat
The postprandial plasma concentration of TRL comloading on FMD were comparable to the effects during the prises both intestinally derived chylomicrons and hepatic placebo period, i.e. 9.063.8 vs. 5.362.6% (Fig. 1) . NTG derived apoB-100-containing TRLs, as a result of reduced response remained unaffected, i.e. 16.865.5 vs.
clearance of VLDL [19] . After entering the circulation, 15.665.0%. During cerivastatin, the adverse effects of fat TRLs are hydrolysed by lipoprotein lipase (LPL) at the loading on FMD were completely abolished, i.e. 7.962.6 vascular endothelium, resulting in the formation of free vs. 8.462.8% (Fig. 1) . Again, NTG response remained fatty acids (FFA) and remnant particles. Evidence has unaffected, i.e. 14.965.7 vs. 14.764.4%. accumulated to show that within the total TG fraction the No significant correlations could be demonstrated beRLPs, derived from exogenous (chylomicron remnants) tween changes in FMD and changes in lipid parameters. In and endogenous origin (b-VLDL and IDL), may be of particular, there was no significant correlation between pivotal importance for the adverse vascular effects. In RLP-C increase and FMD decrease postprandially during support, a positive correlation was shown between RLP-C all treatment periods.
concentration and coronary endothelial dysfunction [7] , Of note, the results of the subject with the blood whereas the correlation between postprandial total TG pressure elevation (systolic blood pressure 150 mmHg and levels and endothelial dysfunction has provided heterogediastolic blood pressure 85 mmHg) were comparable to the neous results [8] [9] [10] 20] . A lack of a direct relation normotensive individuals. Since exclusion of the results between total TG levels and endothelial dysfunction is did not significantly change the results, the data were highlighted by Steinberg et al. [21] , who failed to observe included in the analysis. direct vascular effects of infusion of intralipid in spite of a two-fold rise in total TG levels. In contrast, administration of intralipid with concomitant heparin infusion, which 4. Discussion activates vascular LPL resulting in the formation of FFA and remnant particles, was clearly associated with the In the present study we demonstrate that cerivastatin, onset of endothelial dysfunction [21] . The mechanisms but not gemfibrozil prevents the impairment in FMD after responsible for the adverse vascular effects of RLP and / or FFA remain to be elucidated. Recently, the importance of FMD impairment. However, this may relate to the smaller redox activity of RLP has been highlighted. Accordingly, group size in the present study. in vitro and in vivo studies have shown that administration Besides lipid lowering effects, the statin-associated of antioxidants caused (partial) restoration of endothelial prevention of FMD impairment after a fat load could also dysfunction induced by elevated RLP-C [3, 22] . be related to pleiotropic effects. These 'direct' effects of statins include (amongst others) attenuation of pro-inflam-4.2. Effect of cerivastatin and gemfibrozil on lipid matory pathways (e.g. NFkB downregulation) and upreguprofile and FMD changes lation of anti-atherosclerotic mechanisms (e.g. upregulation of NO-synthase expression) [27] [28] [29] . However, since the In this study, postprandial RLP-C increase was sigbaseline FMD during statin therapy was not significantly nificantly attenuated during cerivastatin therapy, whereas different from the placebo period, statin-induced modipostprandial TG increase was lower but not significantly fications in the changes in 'postprandial' lipid profile seem different from the increase in the placebo period. In this to have a larger impact in the present study. respect, statins are known to induce LDL-receptor gene
In conclusion, we show that cerivastatin therapy preexpression, thereby increasing the number of LDL revents the impairment in FMD after an oral fat load, ceptors resulting in subsequent inhibition of cholesterol whereas gemfibrozil has no protective effect. Taken tosynthesis [23] . Since the LDL receptor is also important gether with the previously reported association of RLP-C for removal of remnant particles, statins can also improve and endothelial dysfunction, the association of beneficial RLP clearance, thereby influencing TG levels as a seceffects on FMD and simultaneous abolition of 'postpranondary effect. In addition, statins decrease hepatic VLDL dial' RLP-C increase during cerivastatin may suggest a secretion, resulting in less IDL / LDL-dense particles, role of RLP in postprandial FMD reduction. whereas the catabolism of apo B-100 containing particles is increased. However, in the present study the latter mechanism seems to be of minor importance, since the
